ListedMainboardHospital & Healthcare ServicesGAUDIUMIVF

Gaudium IVF & Women Health IPO

Gaudium IVF & Women Health IPO is a mainboard IPO raising ₹165 Cr at ₹75 – ₹79 a share. It listed on 27 Feb 2026 and trades at ₹146 today, +84.7% against its issue price of ₹79. It was subscribed 7.27× in total.

79
Issue price
146
Price now
+84.7%
Since issue price
27 Feb 2026
Listed on
7.27×Subscribed (final) · all exchanges

7.3 times more demand than shares on offer

populated partly populated we hold nothing here — the tab says why

How its cohort has done

20 mainboard issues listed in 2026 that we can price today. This is the group this issue belongs to.

+38.9%
Median return since issue price
25%
Now trading below their issue price

Neither figure is a forecast for this issue — they describe what happened to comparable issues. Full cohort analytics →

How the book finished

The category split is the number worth reading, not the total.

QIB1.62×
Non-institutional14×
Retail7.60×

Non-institutional: 14× their allocation. QIB: 1.62×.

See the full split, sub-category by sub-category →

What we hold for this issue

Stated up front on every issue, so a sparse page reads as a fact about the source rather than a broken one.

Category split — who bidQIB, non-institutional and retail, with sub-splits
How demand built over timeOnly one reading so far; the series builds as bidding runs
Price-point demand curveLive only — NSE stops serving this once bidding closes
Lead managers and registrar1 bank
Official documents5 documents
Performance since listingComputed from our own daily closes

What happens when

18 Feb 2026Pre-apply opens
20 Feb 2026Bidding opens
24 Feb 2026Bidding closes
26 Feb 2026Allotment finalised — you find out what you got
25 Feb 2026Money refunded to unsuccessful bidders
27 Feb 2026Shares list and start trading
7 Apr 2026UPI mandate expires

Track GAUDIUM IVF N WOMEN H L

Results, orders, board decisions and every other filing — summarised and sent to your WhatsApp the minute they are out.

Open the company page

Figures are as published by the exchanges and the issuer’s prospectus. MarketPing publishes facts, comparisons and history only — nothing here is a recommendation to apply to this issue, and we do not publish grey market premium.